An observational study of the effect of frailty on treatment modality selection in patients with muscle-invasive bladder cancer: FRART-BC study
Not Applicable
- Conditions
- rinary bladder cancer
- Registration Number
- JPRN-UMIN000038559
- Lead Sponsor
- Hirosaki University School of Medicine
- Brief Summary
Frailty was significantly different between the RC and TMT in patients with MIBC and might be one of the key factors for treatment selection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 169
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with bladder cancer who were not eligible for radical therapy such as radical cystectomy or trimodal therapy for bladder preservation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method